Clinical Trials Browser

Paroxysmal nonkinesigenic dyskinesia, Leukemia, Neoplasm Metastasis, Neuroblastoma, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05974202 2026-04-07

rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder

Phase NA Not yet recruiting

30 enrolled

Lymphoid

Lymphoma, Follicular, Cocaine-Related Disorders

NCT07254793 2026-04-07

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Phase 1 Not yet recruiting

94 enrolled

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Motor Activity, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07514819 2026-04-07

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

Phase NA Not yet recruiting

100 enrolled

LymphoidSarcoma

Bone Neoplasms, Hodgkin Disease, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT07515313 2026-04-07

Expression of CD274 (PD-L1) and CD276 in B-cell Malignancies: A Study by Flowcytometry

Not yet recruiting

159 enrolled

Lymphoid

B-cell Malignancies

NCT07225985 2026-04-03

Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

Phase 1/2 Not yet recruiting

50 enrolled

Lymphoid

Lymphoma, T-Cell

NCT07508995 2026-04-03

A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

Phase 2 Not yet recruiting

40 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07509151 2026-04-03

SOUNDTRACK-C1

Phase 3 Not yet recruiting

420 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, B-Cell

NCT07509385 2026-04-03

The Role of Serum Cytokines IL_17 A and IL_10 in Disease Activity of Acute B Lymphoblastic Leukemia in South Egypt

Not yet recruiting

80 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07221656 2026-04-02

Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration

Not yet recruiting

20 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07422610 2026-04-02

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

Phase 1 Not yet recruiting

24 enrolled

Lymphoid

Lymphoma, Follicular

NCT07506668 2026-04-02

RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Phase 1/2 Not yet recruiting

10 enrolled

Lymphoid

Lymphoma, B-Cell

NCT07507318 2026-04-02

DEL-MRD-CHID

Phase 2 Not yet recruiting

69 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

NCT07505849 2026-04-01

ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma

Phase 2 Not yet recruiting

100 enrolled

Lymphoid

Lymphoma, Follicular

NCT07014293 2026-03-31

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

Phase NA Not yet recruiting

254 enrolled

Lymphoid

Lymphoma

Clinical Trials

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

REBEL

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma

ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma

LANA

Real World Asparaginase Therapy Toxicity

Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

Geriatric-guided Care Versus Conventional Care in Elderly Unfit/Frail Patients With Diffuse Large B-cell Lymphoma in First Line Treatment

Virtual Buddy Movement Therapy for Psychomotor and Social Development in Pediatric Oncology Patients in Remission

ASTRA

CurbMF

Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma

Family-Focused Study to Support Medication for Opioid Use Disorder

TITLE CLL

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And Lymphomas

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

STOP-CLL-DCT

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.

ThINKK-01

rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

Expression of CD274 (PD-L1) and CD276 in B-cell Malignancies: A Study by Flowcytometry

Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

SOUNDTRACK-C1

The Role of Serum Cytokines IL_17 A and IL_10 in Disease Activity of Acute B Lymphoblastic Leukemia in South Egypt

Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

DEL-MRD-CHID

ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors